Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in obese children and adolescents with insulin resistance
NL-OMON39499Phase 3Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in obesity and insulin resistance (IR), sponsored by St. Antonius Ziekenhuis. Primary endpoints: BMI reduction, Insulin resistance by HOMA-IR and 8 more. Started Aug 2011; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NL-OMON39499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39499.